comparemela.com

Latest Breaking News On - Curr oncol - Page 1 : comparemela.com

Jaguar Health to Initiate Commercial Footprint in Cancer Supportive Care at American Society of Clinical Oncology (ASCO) Annual Meeting with Exhibit Booth for FDA-Approved Gelclair Oral Mucositis Product

Jaguar Health to Initiate Commercial Footprint in Cancer Supportive Care at American Society of Clinical Oncology (ASCO) Annual Meeting with Exhibit Booth for FDA-Approved Gelclair Oral Mucositis Product
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.

United-states
Milan
Lombardia
Italy
Italian
American
Maged-ghaly
Pabloc-okhuysen
Lisa-conte
Magdalena-biosciences
Filament-health-corp
Northwell-health-cancer-institute

AURKA Pathway Gains Ground as Targetable Option in Metastatic Breast Cancer

The AURKA inhibitor alisertib has emerged as an agent of particular note, demonstrating early signals of efficacy with a manageable safety profile for the treatment of patients with locally advanced or metastatic breast cancer whose disease is resistant to endocrine therapies.

Mayo-clinic-in-rochester
Minnesota
United-states
American
Karthikv-giridhar
Tufiac-haddad
Antonio-dassoro
Houj-aurora
Digital-health
Mayo-clinic-comprehensive-cancer-center
Mayo-clinic-college-of-medicine
American-society-of-clinical-oncology-annual-meeting

A Majority of Subjects in Jaguar Health's Placebo-Controlled Pivotal Phase 3 OnTarget Trial for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Therapy Chose to Continue on to Stage II

A Majority of Subjects in Jaguar Health's Placebo-Controlled Pivotal Phase 3 OnTarget Trial for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Therapy Chose to Continue on to Stage II
torontotelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from torontotelegraph.com Daily Mail and Mail on Sunday newspapers.

Italy
Milan
Lombardia
Italian
Magdalena-biosciences
Lisa-conte
Jaguar-entheogen-therapeutics-initiative
Napo-pharmaceuticals
Jaguar-animal-health
Jaguar-health-family-of-companies
Filament-health-corp
Jaguar-health-inc

Frontiers | Projected Impact of Weight Gain During the COVID-19 Pandemic on the Future Burden of Cancer in Canada

The COVID-19 pandemic and resulting public health measures have had significant impacts on daily life, including shifts in health behaviours which contribute to weight gain and may increase subsequent risk of chronic diseases such as cancer. Using OncoSim, a web-based microsimulation tool, we estimated the future burden of cancer in Canada by incorporating data on unintentional weight gain among adults during the first year of the COVID-19 pandemic. Population impact measures were estimated until 2042, assuming a 12-year latency period. We estimated 12,160 excess cancer cases and 4,567 excess cancer deaths by 2042 due to COVID-19 related weight gain. The largest estimated impacts were observed for endometrial, kidney and liver cancers among women, with potential impact fractions (PIF) of 2.87%, 1.67% and 1.30%, respectively. For men, the largest mean PIFs were observed for esophageal (2.48%), kidney (1.85%) and liver (1.47%) cancers. Changes in health behavior during the COVID-19 pande

United-states
United-kingdom
Canada
France
Massachusetts
Canadians
Canadian
French
American
British
Bader-eddeen
Canadian-community-health

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.